why choose us

First received: March 16, 2023

Clinical Trial: Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Head and Neck Cancer Survivors

Study Type: INTERVENTIONAL


Official Title: Head and Neck Cancer Survivorship Ototoxicity Screening (SOS) Protocol

Brief Summary: To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Read more